Alterations in heart rate variability in patients undergoing dobutamine stress echocardiography, including patients with neurocardiogenic hypotension

Charles W. Hogue*, Víctor G. Dávila-Román, Phyllis K. Stein, Micha Feinberg, Demetrios G. Lappas, Julio E. Pérez

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Frequency-domain analysis of heart rate variability (HRV) appears to distinguish sympathetic and parasympathetic modulation of heart rate. The effects of acute reflex, as opposed to tonically augmented, cardiac vagal tone on HRV are not clearly defined. Power spectral components of HRV were measured in 36 patients undergoing dobutamine stress echocardiography including during episodes of neurocardiogenically mediated hypotension. The low-frequency (LF; 0.04 to 0.15 Hz) and high-frequency (HF; 0.15 to 0.40 Hz) components of HRV decreased with increasing dose of dobutamine (5 to 40 μg/kg/min) in patients whose systolic blood pressure, compared with baseline, remained within 20 mm Hg (normotensive) or increased >20 mm Hg (hypertensive). The ratio of LF HF became <1 in the hypertensive group at 30 and 40 μg/kg/min of dobutamine. In eight patients in whom apparent neurocardiogenically mediated hypotension developed (decrease in systolic blood pressure >20 mm Hg from baseline), LF and HF measures became significantly higher than those in the patients without hypotension, whereas the LF HF ratio was unchanged. These findings suggest that the HF component of HRV is a reliable measure of reflex-augmented cardiac vagal activity and lend further support to the importance of parasympathetic modulation of the LF component of HRV.

Original languageEnglish (US)
Pages (from-to)1203-1209
Number of pages7
JournalAmerican heart journal
Volume130
Issue number6
DOIs
StatePublished - Dec 1995

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Alterations in heart rate variability in patients undergoing dobutamine stress echocardiography, including patients with neurocardiogenic hypotension'. Together they form a unique fingerprint.

Cite this